FSENX | RYEIX | FSENX / RYEIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 43 years | 27 years | - |
Gain YTD | 14.823 | 10.471 | 142% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2B | 21.5M | 9,279% |
Annual Yield % from dividends | 1.72 | 2.43 | 71% |
Returns for 1 year | 13.64 | 11.68 | 117% |
Returns for 3 years | 84.08 | 58.86 | 143% |
Returns for 5 years | 107.35 | 79.25 | 135% |
Returns for 10 years | 36.34 | -3.69 | -984% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHPIX | 28.12 | 0.30 | +1.08% |
ProFunds Pharmaceuticals UltraSector Inv | |||
VVOSX | 24.79 | 0.22 | +0.90% |
Invesco Value Opportunities R6 | |||
GCVRX | 27.23 | N/A | N/A |
Goldman Sachs Large Cp Val Insghts R | |||
PSSMX | 30.48 | N/A | N/A |
Principal SmallCap S&P 600 Index R3 | |||
ISCGX | 7.20 | N/A | N/A |
Transamerica Small Cap Growth I |